Načítá se...

Meta-analysis of the incidence and risks of interstitial lung disease and QTc prolongation in non-small-cell lung cancer patients treated with ALK inhibitors

BACKGROUND: To conduct a systematic review and meta-analysis to assess the overall incidence and risk of interstitial lung disease (ILD) and QTc prolongation associated with anaplastic lymphoma kinase (ALK)-tyrosine kinase inhibitors (-TKIs) in non-small-cell lung cancer (NSCLC) patients. RESULTS: A...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Oncotarget
Hlavní autoři: Lin, Liping, Zhao, Juanjuan, Kong, Ning, He, Yan, Hu, Jiazhu, Huang, Fuxi, Han, Jianjun, Cao, Xiaolong
Médium: Artigo
Jazyk:Inglês
Vydáno: Impact Journals LLC 2017
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5593649/
https://ncbi.nlm.nih.gov/pubmed/28915678
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.18283
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!